Stanozolol Injection Recalled Due to Sterility Assurance Concerns
Pacific Healthcare, Inc. is recalling Stanozolol 200 mg/ml Injection vials due to FDA inspection findings of GMP violations that may impact sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of infection or serious injury.
Plain-English summary
Pacific Healthcare, Inc. dba B&B Pharmacy is recalling Stanozolol 200 mg/ml Injection, 20 mL vials. The recall was initiated because an FDA inspection identified Good Manufacturing Practice (GMP) violations that potentially impact the product's quality and sterility assurance.
The affected product is a prescription medication distributed in California and New Jersey. Specific lot codes and expiration dates are listed in the recall documentation. The agency has classified this recall as Class II.
Consumers and healthcare providers should stop using the affected vials and contact their pharmacist or the recalling firm for further instructions or a replacement.
The recalled product
- Product
- Stanozolol 200 mg/ml Injection, 20 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA
- Manufacturer
- Pacific Healthcare, Inc dba B&B Pharmacy
- Category
- Drug — Injectable Steroid
- Hazard
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- 07162015@3
- exp 10/14/2015
- 08112015@1
- exp 11/9/2015
Distribution
Part of a larger recall action
This product is one of 16 recalled by Pacific Healthcare, Inc dba B&B Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Pacific Healthcare, Inc dba B&B Pharmacy
See all →- SevereNandrolone Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-18
- SevereB&B Pharmacy Recalls PAPA/PHENTO Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-18
- SevereTestosterone Cypionate Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-18
- SeverePGE 25mcg/ml Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-18
- SevereTestosterone Propionate Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-11-18
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29